Additional Analysis from the SMART Trial: Late Breaking from

Additional analysis from the SMall Annuli Randomized To Evolut or SAPIEN (SMART) study demonstrated clinical non-inferiority of self-expanding valves (SEV) versus balloon-expandable valves (BEV) in aortic stenosis patients undergoing transcatheter aortic valve replacement (TAVR) and confirmed valve performance superiority over time based on hemodynamics. SCAI TV interviewed Howard C. Herrmann, MD, MSCAI, John W. Bryfogle, Professor of Cardiovascular Medicine and Surgery, Health System Director and Section Chief of Interventional Cardiology, Perelman School of Medicine at the University of Pennsylvania, and lead author of the study. More info: scai.org/smart...